CDH2 and neoplasm: In NSCLC, the downregulation or loss of CDH1 (Fan et al., 2019; Lofiego et al., 2021) and upregulation of CDH2 is frequently observed and is associated with increased invasiveness and the ability of tumor cells to detach from the primary tumor site.